Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial | Zendy

Helena von Hertzen | Zendy; Gilda Piaggio | Zendy; Daniel Wojdyla | Zendy; N T Huong | Zendy; Lena Marions | Zendy; G G Okoev | Zendy; Archil Khomassuridze | Zendy; Attila Keresztúri | Zendy; S. Mittal | Zendy; R. Nair | Zendy; Rekha G. Daver | Zendy; A. PretnarDarovec | Zendy; Kim Dickson | Zendy; N. D. Hinh | Zendy; Nirong Bao | Zendy; Hoang Thi Diem Tuyet | Zendy; Alexandre Peregoudov | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial

Author(s) -

Helena von Hertzen,

Gilda Piaggio,

Daniel Wojdyla,

N T Huong,

Lena Marions,

G G Okoev,

Archil Khomassuridze,

Attila Keresztúri,

S. Mittal,

R. Nair,

Rekha G. Daver,

A. PretnarDarovec,

Kim Dickson,

N. D. Hinh,

Nirong Bao,

Hoang Thi Diem Tuyet,

Alexandre Peregoudov

Publication year - 2008

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/den328

Subject(s) - misoprostol , medicine , sublingual administration , abortion , obstetrics , pregnancy , placebo , medical abortion , gestation , randomized controlled trial , gynecology , anesthesia , surgery , genetics , alternative medicine , pathology , biology

To identify an effective misoprostol-only regimen for the termination of second trimester pregnancy, we compared sublingual and vaginal administration of multiple doses of misoprostol in a randomized, placebo-controlled equivalence trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research